^
    Back
    Association details:
    Biomarker:INHBA overexpression
    Cancer:Gastric Cancer
    Drug Class:Immunotherapy
    Direction:Sensitive
    Evidence:
    Evidence Level:
    Sensitive: C3 – Early Trials
    New
    Source:
    Sci Rep
    Title:

    Identification of INHBA as a potential biomarker for gastric cancer through a comprehensive analysis

    Published date:
    08/01/2023
    Excerpt:
    INHBA is a promising predictor of immunotherapy response, with higher levels of INHBA indicating greater sensitivity.
    DOI:
    10.1038/s41598-023-39784-1